These medications are used to treat type 2 diabetes and obesity
Simultaneously, they suppress glucagon secretion, slow gastric emptying, and act on satiety centres in the brain to reduce appetite
Vuong HG, Kondo T, Pham TQ, Oishi N, Mochizuki K, Nakazawa T, et al
[2] If retatrutide is working as intended, several early indicators may become apparent over the course of treatment: Reduced appetite and food cravings: One of the most consistent early signs is a noticeable decrease in hunger, particularly between meals
Tirzepatide treatment follows a structured dose escalation schedule designed to minimize gastrointestinal side effects while achieving therapeutic efficacy
If you want the full breakdown of how to compare those two numbers correctly, read Burst C Rating vs Continuous C Rating: What Actually Matters in a LiPo Battery